» Articles » PMID: 31899194

Long Non-coding RNA Signature in Gastric Cancer

Overview
Journal Exp Mol Pathol
Publisher Elsevier
Date 2020 Jan 4
PMID 31899194
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer as a common human malignancy has been associated with aberrant expressions of several coding and non-coding genes. Long non-coding RNAs (lncRNAs) as regulators of gene expressions at different genomic, transcriptomic and post-transcriptomic levels are among putative biomarkers and therapeutic targets in gastric cancer. In the present study, we have searched available literature and listed lncRNAs that are involved in the pathogenesis of gastric cancer. In addition, we discuss associations between expressions of these lncRNAs and tumoral features or risk factors for gastric cancer. Based on the established role of lncRNAs in regulation of genomic stability, cell cycle, apoptosis, angiogenesis and other aspects of cell physiology, the potential of these transcripts as therapeutic targets in gastric cancer should be evaluated in future studies.

Citing Articles

Non-coding RNA in the Regulation of Gastric Cancer Tumorigenesis: Focus on microRNAs and Exosomal microRNAs.

Vakilzadehian N, Moradi Y, Allela O, Al-Hussainy A, Ali Al-Nuaimi A, Kadhim A Al-Hussein R Int J Mol Cell Med. 2025; 13(4):417-435.

PMID: 39895920 PMC: 11786126. DOI: 10.22088/IJMCM.BUMS.13.4.417.


Exosome-mediated transfer of lncRNA RP3-340B19.3 promotes the progression of breast cancer by sponging miR-4510/MORC4 axis.

Wang B, Mao J, Wang L, Zhao Y, Wang B, Yang H Cancer Cell Int. 2024; 24(1):312.

PMID: 39256868 PMC: 11389435. DOI: 10.1186/s12935-024-03490-3.


BRD4 expression and its regulatory interaction with miR-26a-3p, DLG5-AS1, and JMJD1C-AS1 lncRNAs in gastric cancer progression.

Ahmadpour Youshanlui M, Yari A, Bahojb Mahdavi S, Amini M, Baradaran B, Ahangar R Discov Oncol. 2024; 15(1):356.

PMID: 39152304 PMC: 11329449. DOI: 10.1007/s12672-024-01230-7.


A depression-related lncRNA signature predicts the clinical outcome and immune characteristics of gastric cancer.

Ning B, Huang T, Liu Y, Wei Y Heliyon. 2024; 10(15):e34399.

PMID: 39144985 PMC: 11320146. DOI: 10.1016/j.heliyon.2024.e34399.


Uncovering the ceRNA Network Related to the Prognosis of Stomach Adenocarcinoma Among 898 Patient Samples.

Liu Z, Liu F, Petinrin O, Wang F, Zhang Y, Wong K Biochem Genet. 2024; 62(6):4770-4790.

PMID: 38361095 PMC: 11604743. DOI: 10.1007/s10528-023-10656-7.